Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.[1]
- Market Cap ₹ 118 Cr.
- Current Price ₹ 63.0
- High / Low ₹ 98.7 / 55.2
- Stock P/E 26.1
- Book Value ₹ 18.3
- Dividend Yield 0.00 %
- ROCE 0.83 %
- ROE 0.56 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.44 times its book value
- Company has a low return on equity of -10.1% over last 3 years.
- Earnings include an other income of Rs.6.46 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108.38 | 117.93 | 129.61 | 140.56 | 149.19 | 144.59 | 111.87 | 69.24 | 86.18 | 85.95 | 59.01 | -0.00 | 0.05 | |
| 99.39 | 110.37 | 123.31 | 139.64 | 147.44 | 146.94 | 114.57 | 75.58 | 82.74 | 81.38 | 60.22 | 2.14 | 1.54 | |
| Operating Profit | 8.99 | 7.56 | 6.30 | 0.92 | 1.75 | -2.35 | -2.70 | -6.34 | 3.44 | 4.57 | -1.21 | -2.14 | -1.49 |
| OPM % | 8.29% | 6.41% | 4.86% | 0.65% | 1.17% | -1.63% | -2.41% | -9.16% | 3.99% | 5.32% | -2.05% | -2,980.00% | |
| 6.85 | 7.63 | 7.21 | 7.95 | 8.44 | 10.03 | 11.11 | 15.10 | 7.39 | 6.64 | 64.88 | 2.72 | 6.46 | |
| Interest | 0.46 | 0.51 | 0.40 | 0.46 | 0.38 | 0.51 | 7.81 | 7.20 | 6.56 | 6.07 | 4.30 | 0.01 | 0.00 |
| Depreciation | 1.99 | 2.71 | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | -0.00 | 0.00 |
| Profit before tax | 13.39 | 11.97 | 9.95 | 4.47 | 5.60 | 2.79 | -11.93 | -11.32 | -8.26 | -7.01 | 50.01 | 0.57 | 4.97 |
| Tax % | 34.43% | 34.25% | 35.58% | 30.20% | 40.54% | 26.16% | -25.48% | -30.48% | 0.12% | 120.97% | 9.36% | 31.58% | |
| 8.78 | 7.86 | 6.42 | 3.11 | 3.32 | 2.06 | -8.89 | -7.87 | -8.27 | -15.48 | 45.32 | 0.39 | 4.53 | |
| EPS in Rs | 4.72 | 4.23 | 3.45 | 1.67 | 1.78 | 1.10 | -4.74 | -4.20 | -4.41 | -8.26 | 24.18 | 0.21 | 2.42 |
| Dividend Payout % | 10.60% | 11.84% | 14.50% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 175.93% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -26% |
| 5 Years: | 15% |
| 3 Years: | 27% |
| TTM: | 240% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 4% |
| 3 Years: | 3% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -11% |
| 3 Years: | -10% |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18.61 | 18.61 | 18.62 | 18.68 | 18.70 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
| Reserves | 66.20 | 72.63 | 79.02 | 80.87 | 84.35 | 86.62 | 77.65 | 69.99 | 61.37 | 45.42 | 90.71 | 11.45 | 15.62 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 64.34 | 57.17 | 53.41 | 46.40 | -0.00 | -0.00 | -0.00 | |
| 16.67 | 19.68 | 32.55 | 31.14 | 46.03 | 45.46 | 32.80 | 23.18 | 27.37 | 27.42 | 6.41 | 6.62 | 2.81 | |
| Total Liabilities | 101.48 | 110.92 | 130.19 | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 | 37.19 |
| 17.63 | 17.71 | 24.50 | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | -0.00 | -0.00 | -0.00 | |
| CWIP | 0.64 | 0.64 | 0.36 | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 83.21 | 92.57 | 105.33 | 105.49 | 124.57 | 128.26 | 112.38 | 100.22 | 103.23 | 90.59 | 115.88 | 36.83 | 37.19 | |
| Total Assets | 101.48 | 110.92 | 130.19 | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 | 37.19 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.81 | 4.39 | 10.47 | -8.58 | 8.79 | -15.97 | -0.30 | -0.86 | 6.84 | 5.61 | -7.30 | 1.54 | |
| -0.55 | 5.34 | -21.88 | 13.47 | -1.56 | 6.34 | 49.88 | -27.51 | 8.23 | 0.50 | 119.70 | -29.10 | |
| -1.10 | -0.00 | -1.09 | -0.97 | 0.05 | 0.15 | -11.57 | -7.25 | -10.10 | -12.65 | -10.85 | -79.65 | |
| Net Cash Flow | 3.16 | 9.73 | -12.51 | 3.92 | 7.28 | -9.48 | 38.01 | -35.62 | 4.98 | -6.54 | 101.55 | -107.21 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.13 | 13.03 | 16.93 | 14.49 | 14.68 | 24.39 | 12.17 | 11.02 | 9.32 | 13.50 | -0.00 | |
| Inventory Days | 4.02 | 13.24 | 35.39 | 28.37 | 22.30 | 18.04 | 22.44 | 42.32 | 39.89 | 31.71 | -0.00 | |
| Days Payable | 153.41 | 169.39 | 286.36 | 173.78 | 277.45 | 257.22 | 323.72 | 373.05 | 428.91 | 584.69 | ||
| Cash Conversion Cycle | -136.26 | -143.11 | -234.05 | -130.92 | -240.47 | -214.79 | -289.11 | -319.72 | -379.70 | -539.47 | -0.00 | |
| Working Capital Days | 187.38 | 163.79 | 126.13 | 152.64 | 131.84 | 155.53 | -55.01 | 114.55 | 21.60 | 183.80 | -8.35 | |
| ROCE % | 17.17% | 14.19% | 11.83% | 5.02% | 5.90% | 3.24% | -3.04% | -7.15% | -1.25% | -0.77% | -3.29% | 0.83% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
1 Dec - GST show-cause originally INR 3,454.54L; finalized demand INR 4.19L (Apr 2022–Mar 2023).
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
26 Nov - GST order confirms INR 4.29 lakh demand for Apr 2021–Mar 2022; balance dropped.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
26 Nov - GST show cause for Apr 2020–Mar 2021; order confirms INR 2.78 lakh demand (incl. interest/penalty).
-
Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 30Th October 2025.
18 Nov - No re-lodgement requests received/processed under SEBI special window as of Nov 6, 2025.
-
Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 30Th October 2025.
18 Nov - SEBI-window report: zero physical share transfer re-lodgement requests for month ended Oct 30, 2025 (status Nov 6, 2025).
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
FMHL is a subsidiary of Fortis Hospitals Limited. The company used to run a multi-speciality hospital facility in Chennai. The hospital building
was owned by a fellow subsidiary, Fortis Health Management Limited. The Parent Company has 1 wholly owned subsidiary company, Malar Stars Medicare Limited